INCREASING TIM-3+T CELLS IN PERIPHERAL BLOOD OF PEDIATRIC PATIENTS WITH RELAPSE B-ALL AFTER HAPLOIDENTICAL ALLO-HSCT

被引:0
|
作者
Tsvetkova, Liubov [1 ]
Epifanovskaya, Olga [1 ]
Babenko, Elena [1 ]
Paina, Olesya [1 ]
Kozhokar', Polina [1 ]
Rakhmanova, Zhemal [1 ]
Yudinceva, Olesya [1 ]
Osipova, Anna [1 ]
Ryabenko, Sabina [1 ]
Dobrovolskaya, Elena [1 ]
Moiseev, Ivan [1 ]
Kulagin, Alexandr [1 ]
Zubarovskaya, Ludmila [1 ]
机构
[1] Pavlov Univ, RM Gorbacheva Res Inst, St Petersburg, Russia
基金
俄罗斯科学基金会;
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P680
引用
收藏
页码:613 / 614
页数:2
相关论文
共 50 条
  • [21] allo-HSCT后复发/难治性B-ALL患者行CD19 CAR-T治疗的疗效及安全性
    黄成莹
    顾康生
    陶千山
    安福润
    翟志敏
    现代医药卫生, 2023, 39 (16) : 2701 - 2706
  • [22] CD19-Targeted CAR-T Cell Therapy for 32 B-Cell Acute Lymphoblastic Leukemia (B-ALL) PatientsWHO Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation (ALLO-HSCT)
    Zhang, Xian
    Yang, Junfang
    Zhang, Jianping
    Li, Jingjing
    Li, Wenqian
    Lu, Peihua
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 171 - 172
  • [23] Chidamide maintenance therapy after allo-HSCT in SET-NUP214 fusion positive T-ALL patients: A report of two cases
    Song, Jingyu
    Liu, Jie
    Guo, Dan
    Li, Huibo
    Fan, Shengjin
    TRANSPLANT IMMUNOLOGY, 2024, 87
  • [24] T CELL EXHAUSTION CHARACTERIZED BY COMPROMISED MHC CLASS I AND II RESTRICTED CYTOTOXIC ACTIVITY ASSOCIATES WITH ACUTE B LYMPHOBLASTIC LEUKEMIA RELAPSE AFTER ALLO-HSCT
    Liu, L.
    Chang, Y.
    Xu, L.
    Zhang, X.
    Wang, Y.
    Liu, K.
    Huang, X.
    HAEMATOLOGICA, 2017, 102 : 193 - 193
  • [25] Treatment and outcomes of patients with B-ALL relapse after CD19 CAR-T therapy
    Wang, Yu
    Xue, Yu-juan
    Zuo, Ying-xi
    Jia, Yue-ping
    Lu, Ai-dong
    Zeng, Hui-min
    Zhang, Le-ping
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [26] TREATMENT OF RELAPSED PEDIATRIC B-CELL PRECURSOR ALL WITH TRANSLOCATION T(12;21)(P13;Q22) BY MEANS OF ALLO-HSCT
    Mamaev, N. Nikolaevich
    Semyenova, E. V.
    Stancheva, N. V.
    Katerina, V. A.
    Evdokimov, A. V.
    Barkhatov, I. M.
    Boychenko, E. G.
    Gindina, T. L.
    Kravtsova, V. M.
    Zubarovskaya, L. S.
    Afanasyev, B. V.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S105 - S105
  • [27] Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review
    Li Gao
    Jun Lu
    Jie Li
    Yixin Hu
    Ye Lu
    Weiwei Du
    Shaoyan Hu
    International Journal of Hematology, 2023, 117 : 781 - 785
  • [28] Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review
    Gao, Li
    Lu, Jun
    Li, Jie
    Hu, Yixin
    Lu, Ye
    Du, Weiwei
    Hu, Shaoyan
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (05) : 781 - 785
  • [29] Significant Long-Term Benefits of CAR T-Cell Therapy Followed By a Second Allo-HSCT for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) Patients Who Relapsed after an Initial Transplant
    Zhang, Jianping
    Yang, Junfang
    Zhang, Xian
    Li, Jingjing
    Cao, Xingyu
    Zhao, Yanli
    Wei, Zhijie
    Liu, Deyan
    Xiong, Min
    Lu, Yue
    Zhou, Jiarui
    Sun, Ruijuan
    Lu, Peihua
    BLOOD, 2020, 136
  • [30] Efficacy and Safety of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for 67 Pediatric Patients with High Risk T-Cell Acute Lymphoblastic Leukemia (T-ALL)
    Sun, Rui-Juan
    Wei, Zhi-Jie
    Liu, De-Yan
    Cao, Xing-Yu
    Zhang, Jian-Ping
    Xiong, Min
    Zhao, Yan-Li
    Zhou, Jia-Rui
    Lu, Yue
    Lu, Pei-Hua
    Lu, DaoPei
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)